RCM Technologies, Inc. Announces Fourth Quarter and Full

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RCM Technologies, Inc. Announces Fourth Quarter and Full Year 2014 Results

PENNSAUKEN, N.J., March 4, 2015 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (Nasdaq: RCMT ), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology, engineering and specialty health care services, today announced financial results for the fourteen and fifty-three week periods ended January 3, 2015.

The Company reported revenues of $49.3 million for the fourteen week period ended January 3, 2015, a 7.5% increase over $45.8 million for the thirteen week period ended December 28, 2013 (comparable prior year period). Operating income before severance and other charges was $2.6 million for the fourteen week period ended January 3, 2015, a 16.6% increase over $2.2 million for the comparable prior year period. Net income for the fourteen week period ended January 3, 2015 was $1.7 million, or $0.14 per diluted share, as compared to a net loss of $1.6 million, or $0.13 per diluted share, for the comparable prior year period.

The Company reported revenues of $193.8 million for the fifty-three week period ended January 3, 2015, a 13.5% increase over $170.8 million for the fifty-two week period ended December 28, 2013 (comparable prior year period). Operating income before severance and other charges was $10.6 million for the fifty-three week period ended January 3, 2015, a 37.3% increase over $7.7 million for the comparable prior year period. Net income for the fifty-three week period ended January 3, 2015 was $6.8 million, or $0.54 per diluted share, as compared to $2.0 million, or $0.16 per diluted share, for the comparable prior year period.

Rocco Campanelli , President and Chief Executive Officer of RCM Technologies, commented, "Our outstanding fiscal 2014 performance was a direct result of the efforts of our valuable employees. I feel privileged to lead RCM as we grew revenues, gross profit and operating income before severance and other charges by 13.5%, 16.5% and 37.3%, respectively. While everyone at RCM contributed to the great results this year, I want to publicly recognize four "All-Star" leaders: Tim Brandt who runs our Information Technology Consulting & Solutions Group; Bill McGuckin who runs our Life Sciences Solutions and East Staffing Practice in our Information Technology segment; Dan White who leads our Canadian Energy Services Group in our Engineering segment; and Rick Wood who leads our Aerospace Technical Publications Group in our Engineering segment. I want to thank and congratulate these four leaders and their entire teams for spectacular performance in fiscal 2014. As we look to fiscal 2015, we know that exceeding our 2014 performance will be a challenge but it's one our entire leadership team has embraced. I'm optimistic we can continue the momentum into 2015 and beyond. In addition to focusing on growing our operating income, we have challenged our leadership team to make significant progress in expanding our service offerings in strategic areas and adding several new multi-million dollar clients in 2015 as we look to strengthen RCM."

Kevin Miller , Chief Financial Officer of RCM Technologies, added, "All three of our segments made significant contributions to our highest operating income since fiscal 2002. We expect to continue our operating income growth in fiscal 2015. Our business has significant operating leverage as demonstrated by our 37.3% growth in operating income before severance and other charges on 16.5% growth in gross profit. For 2015, we plan to focus on continuing to leverage gross profit dollar growth through a combination of revenue growth and improvements to our gross margin. Furthermore, over the past two years we have returned $3.00 per share in special distributions, the majority of which are reflected in 1099s as tax advantageous return of capital to shareholders. We believe this demonstrates our commitment to being good stewards of capital and maximizing return on shareholder investment. In 2015 we expect to generate significant free cash flow compared to 2014 as the result of improved working capital management and a further increase in operating income. In 2015 we anticipate being in a position to aggressively reduce our fiscal 2014 ending net debt position of $13.6 million."

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services. RCM is an innovative leader in the delivery of these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America. Additional information can be found at www.rcmt.com .

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should" or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expected demand for our services and expectations regarding our revenues, the Company's ability to continue to utilize goodwill, to continue to increase gross margins, to achieve and manage growth, to develop and market new applications and services, risks relating to the acquisition and integration of acquired businesses, the ability of the Company to consummate acquisitions as to which it executes non-binding letters of intent, demand for new services and applications, timing of demand for services, industry strength and competition, initiatives to reduce our indebtedness, initiatives to enhance shareholder value and returns and general economic factors. Such statements are based on current expectations that involve a number of known and unknown risks, uncertainties and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow

RCM Technologies, Inc.
Condensed Consolidated Statements of Income 
(Unaudited)
 (In Thousands, Except Per Share Amounts)
     
  Fourteen Thirteen
  Week Periods Ended
  January 3, December 28,
  2015  2013
Revenues $49,310 $45,849
Cost of services  35,990 34,055
Gross profit 13,320 11,794
Selling, general and administrative 10,380 9,263
Depreciation and amortization 318 282
Operating income before severance and other charges 2,622 2,249
Severance and other charges -- 4,728
Operating income (loss) 2,622 (2,479)
Other income (expense), net 102 (42)
Income (loss) before income tax effect  2,724 (2,521)
Income tax expense (benefit)  1,007 (939)
Net income (loss) $1,717 ($1,582)
     
Diluted net earnings (loss) per share $0.14 ($0.13)
     
  Fifty-Three Fifty-Two
  Week Periods Ended
  January 3, December 28,
  2015  2013
Revenues $193,770 $170,778
Cost of services  142,077 126,417
Gross profit 51,963 44,361
Selling, general and administrative 39,868 35,514
Depreciation and amortization 1,203 1,111
Operating income before severance and other charges 10,622 7,736
Severance and other charges 104 5,181
Operating income 10,518 2,555
Other income, net 83 32
Income before income taxes  10,601 2,587
Income tax expense  3,787 597
Net income $6,814 $1,990
     
Diluted net earnings per share $0.54 $0.16
     
 
RCM Technologies, Inc.
Summary Consolidated Selected Balance Sheet Data
 (In Thousands)
     
  January 3, December 28,
  2015 2013
Cash and cash equivalents  $6,411 $9,317
Accounts receivable, net $59,187 $55,726
Total current assets $72,579 $72,704
Total assets $87,273 $86,524
Total current liabilities $23,633 $24,739
Borrowing under line of credit $20,000 $ --
Net debt (borrowings less cash) $13,589 $ --
Total liabilities $44,408 $25,146
Stockholders' equity $42,865 $61,378
 
 
RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
 (Unaudited)
(In Thousands)
     
  Fourteen Thirteen
  Week Periods Ended
  January 3, December 28,
  2015  2013
Net income (loss) $1,717 ($1,582)
Adjustments to reconcile net income to cash provided by operating activities 1,161 (548)
Changes in operating assets and liabilities    
Accounts receivable 711 (1,418)
Transit accounts receivable 3,140 1,432
Prepaid expenses and other current assets (68) (636)
Accounts payable and accrued expenses (2,020) (1,502)
Transit accounts payable (362) (1,872)
Accrued payroll and related costs (1,439) 2,187
Income taxes payable 157 (593)
Total adjustments 1,280 (2,950)
Cash provided by (used in) operating activities $2,997 ($4,532)
     
Net cash used in investing activities (138) (292)
Net cash (used in) provided by financing activities (4,863) 16
Effect of exchange rate changes 110 76
Decrease in cash and cash equivalents ($1,894) ($4,732)
     
     
  Fifty-Three Fifty-Two
  Week Periods Ended
  January 3, December 28,
  2015  2013
Net income $6,814 $1,990
Adjustments to reconcile net income to cash provided by operating activities 4,739 703
Changes in operating assets and liabilities    
Accounts receivable (4,934) (12,473)
Transit accounts receivable 156 6,073
Prepaid expenses and other current assets (494) 46
Accounts payable and accrued expenses (2,988) 3,676
Transit accounts payable 2,753 (8,052)
Accrued payroll and related costs (2,321) 3,951
Income taxes payable 456 294
Total adjustments (2,633) (5,782)
Cash provided by (used in) operating activities $4,181 ($3,792)
     
Net cash used in investing activities (2,161) (1,322)
Net cash (used in) provided by financing activities (4,571) 290
Effect of exchange rate changes (355) 18
Decrease in cash and cash equivalents ($2,906) ($4,806)
 
 
RCM Technologies, Inc.
Summary of Selected Income Statement Data
 (Unaudited)
(In Thousands)
         
  Fourteen Week Period Ended January 3, 2015
    Information Specialty  
   Engineering Technology Health Care Consolidated
         
Revenue $24,113 $15,126 $10,071 $49,310
Cost of services 18,189 10,544 7,257 35,990
Gross Profit $5,924 $4,582 $2,814 $13,320
Gross Margin 24.6% 30.3% 27.9% 27.0%
         
         
  Thirteen Week Period Ended December 28, 2013
    Information Specialty  
   Engineering Technology Health Care Consolidated
         
Revenue $23,478 $13,885 $8,486 $45,849
Cost of services 18,443 9,704 5,908 34,055
Gross Profit $5,035 $4,181 $2,578 $11,794
Gross Margin 21.4% 30.1% 30.4% 25.7%
         
         
  Fifty-Three Week Period Ended January 3, 2015
    Information Specialty  
   Engineering Technology Health Care Consolidated
         
Revenue $99,728 $59,202 $34,840 $193,770
Cost of services 75,887 41,278 24,912 142,077
Gross Profit $23,841 $17,924 $9,928 $51,693
Gross Margin 23.9% 30.3% 28.5% 26.7%
         
         
  Fifty-Two Week Period Ended December 28, 2013
    Information Specialty  
   Engineering Technology Health Care Consolidated
         
Revenue $86,742 $55,263 $28,773 $170,778
Cost of services 67,005 39,412 20,000 126,417
Gross Profit $19,737 $15,851 $8,773 $44,361
Gross Margin 22.8% 28.7% 30.5% 26.0%

RCM Technologies, Inc. 2500 McClellan Avenue Pennsauken, NJ 08109 Tel: 856.356.4500 Fax: 856.356.4600 www.rcmt.com Corporate Contacts: Rocco Campanelli President & CEO Kevin D. Miller Chief Financial Officer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading